Skip to content

Boston Scientific BSX Accounts Receivable

Accounts Receivable at other companies

Abbott logo
AbbottABT
$8.6B+7.9%
TFX
TeleflexTFX
$365.53M-21.3%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$19.05B+6.7%
Stryker logo
StrykerSYK
$3.74B-4.5%
Haemonetics logo
HaemoneticsHAE
$216.86M+7.0%
CONMED logo
CONMEDCNMD
$239.77M+2.4%

Other financials

Income statement

See full
Revenue$5.4B+7.5%
Gross profit$3.8B+12.4%
Operating income$1.2B+43.8%
Net income$907.0M+14.1%
EPS (diluted)$0.61+15.1%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$68.43B-56.7%
P/E18.6×-44.6×
P/S3.3×-5.3×

Profitability

See full
Gross margin69.9%+1.7pp
Operating margin19.8%+2.8pp
Net margin17.5%+4.0pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableGrossCurrent.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's accounts receivable?
Boston Scientific (BSX) reported accounts receivable of $3.15B in Q1 2026.
How has Boston Scientific's accounts receivable changed year-over-year?
Boston Scientific's accounts receivable increased by 12.4% year-over-year, from $2.81B to $3.15B.
What is the long-term trend for Boston Scientific's accounts receivable?
Over 5 years (2020 to 2025), Boston Scientific's accounts receivable has grown at a 13.3% compound annual growth rate (CAGR), from $1.64B to $3.06B.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.